Tissium has raised €60M to carry the world’s only FDA-cleared sutureless nerve repair system into US operating rooms. The Paris medtech wants to swap the surgeon’s needle for a dab of light-cured glue. For a severed nerve, the standard repair has barel…
Bristol fusion startup Astral Systems has raised £23mn to scale the medical isotopes that cancer scans depend on. The Astral Systems £23M round backs a rare fusion company that already runs reactors and earns revenue. Most fusion companies promise clea…
UPS has announced a $48 million investment in 27 temperature-controlled freight cross-dock facilities spanning the Americas, Europe, and Asia. The facilities are designed for short-term storage between air and ground movements while maintaining specifi…
Most of what makes American healthcare expensive happens before a doctor is ever in the room, and after. Someone schedules the appointment, confirms the insurance, works out what the patient owes, and chases the payer when a claim stalls. It is slow, f…
Smart rings, glasses, earbuds, and glucose patches are turning ordinary life into a stream of nudges, warnings, and tiny corrections.
Two AI systems have matched, and in places beaten, doctors at diagnosing patients and planning their treatment. Then again, none of the patients were real. The results, published in Nature this week, are some of the strongest evidence yet that speciali…
Almost every AI tool aimed at the NHS is built for clinicians. Frontier Health raised $16M to build for the people behind them. The London startup announced a $16M seed round led by Atomico, with firstminute capital and XYZ Venture Capital also taking …
Midjourney, the company best known for turning text prompts into images, has announced something it has never made before: hardware. And not a phone case or a pair of glasses, but a full-body medical scanner. At an event in San Francisco on June 17, fo…
Telepatia, an AI clinical assistant built for Latin American healthcare, has raised $33 million in a Series A led by Andreessen Horowitz. The company wants to reach half of the region’s 1.9 million doctors by the end of 2027. Total funding is now $42 m…
Neuralink has dominated the brain-chip story for two years. It now has a serious challenger with a patient of its own. Paradromics, an Austin neurotech firm, has implanted its Connexus brain-computer interface in the first participant of its FDA-approv…